Embecta

Embecta Altman Z-Score

The Altman Z-Score of Embecta (EMBC) as of Oct 18, 2026 is 1.60. In the previous year, Altman Z-Score was 0.89 — a change of 79.32% (higher).

Altman Z-Score

1.60

YoY

79.32%

Last updated:

Altman Z-Score of Embecta is 2025 1.60 . Altman Z-Score of Embecta was 2024 0.89 . It decreases by 79.32% higher compared to the previous year.

The Embecta Altman Z-Score history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Altman Z-Score
Date
Altman Z-Score
Jan 1, 2019
6.28 USD
Jan 1, 2020
5.60 USD
Jan 1, 2021
5.21 USD
Jan 1, 2022
1.61 USD
Jan 1, 2023
1.08 USD
Jan 1, 2024
0.89 USD
Jan 1, 2025
1.60 USD
The Embecta Altman Z-Score history
YEARAltman Z-ScoreYoY
1.60+79.32%
0.89-17.51%
1.08-32.71%
1.61-69.13%
5.21-6.99%
5.60-10.88%
6.28—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Embecta Stock analysis

What does Embecta do? Embecta Corp, headquartered in Parsippany, New Jersey, operates in the Health Care sector, manufacturing and distributing medical devices for diabetes treatment. The company employs 1,850 full-time staff and offers a portfolio including pen needles, syringes, safety injection devices, and a digital application for diabetes management. Its products, such as sterile single-use pen needles and safety pen needles with automatic shields, are designed to enhance user safety and convenience. Embecta distributes through retail, hospital, pharmacy, and institutional channels. Embecta is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Embecta stock

Altman Z-Score of Embecta is 1.60 in 2025.

On Eulerpool you can find the complete historical development of Altman Z-Score Embecta since 2006 – with annual values, charts, and detailed analysis.

The Altman Z-Score predicts bankruptcy probability using five financial ratios. Scores above 3.0 indicate safety, below 1.8 suggests distress risk.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — Embecta

All Key Metrics — Embecta